Rajeev Sivasankaran
Senior Vice President and Head of Neuroscience Voyager Therapeutics
Seminars
Wednesday 10th December 2025
Advancing a Brain-Targeted AAV Gene Therapy for Alzheimer’s Disease
9:00 am
- Evaluating functional RNA silencing in the brain
- Advancing brain-targeted viral vector design
- Exploring the path from preclinical success to clinical impact
